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Cell penetrating peptides (CPPs) with intrinsic
biological activities offer a novel strategy for the
modulation of intracellular events. QSAR analysis
identified CPPs within human cytochrome c. Two
such sequences, Cyt c77–101 and Cyt c86–101, induced
tumor cell apoptosis, thusmimicking the role of Cyt c
as a key regulator of programmed cell death. Quanti-
tative analyses confirmed that Cyt c77–101 is an ex-
tremely efficient CPP. Thus, Cyt c77–101 was selected
for modification to incorporate target-specific pep-
tidyl motifs. Chimeric N-terminal extension with a
target mimetic of FG nucleoporins significantly
enhanced the apoptogenic potency of Cyt c77–101 to
a concentration readily achievable in vivo. Moreover,
this construct, Nup153-Cyt c, facilitates the dramatic
redistribution of nuclear pore complex proteins and
thus propounds the nuclear pore complex as a novel
target for the therapeutic induction of apoptosis.
INTRODUCTION
Protein interfaces facilitatemolecular recognition events that influ-
ence many aspects of cellular physiology and pathology. Mimetic
peptides that include sequences derived from protein interfaces
and other functional domains can potentially make multiple
contacts with their target proteins. Subsequently, these binding
eventsmay initiate a selectivemodulatory actionakin to the parent
signal transduction protein. For example, a decapeptide mimetic
of the carboxyl terminus of Gi3a (KNNLKECGLY, Gi3a
346–355),
a component of heterotrimeric G proteins, promotes the dual
phosphorylation of p42/p44 MAP kinases when translocated into
cells by the cell penetrating peptide (CPP) transportan-10 (Jones
et al., 2005). Related studies further identified induction of mast
cell secretion following intracellular delivery of peptides derived
from protein kinase C and the C-terminal juxtamembrane region
of the central cannabinoid (CB1) receptor (Howl et al., 2003).
Such results clearly demonstrate that small- to medium-sized
peptides, delivered to an appropriate intracellular compartment,
canmodulate common signal transduction pathways that controlChemistry & Biology 17,both acute and chronic features of cellular physiology and
pathology. Since corrupted signaling events often underpin
many diseased states such as cancer, these studies also
exemplify the potential of mimetic peptides to target and
specifically modulate novel therapeutic loci that underlie cellular
proliferation, apoptosisanddifferentiation. Todate, several exem-
plary studies have propounded the utility of mimetic peptides for
such purposes and among which include, suppression of malig-
nant cells in vivo by the intracellular delivery of a proteolytically
resistant retro-inverso mimetic corresponding to the C-terminal
of the tumor suppressor p53 (Snyder et al., 2004) and abrogation
of breast cancer cellular proliferation by a cell-permeable 22
amino acid peptide derived from the N-terminal of the tumor
suppressor protein p14ARF (Johansson et al., 2008). Similarly,
an octameric mimetic of the N-terminal of Smac/Diablo, when
fused to the CPP penetratin, binds to inhibitor of apoptosis
proteins (IAPs)withaconsequential liberationof sequesteredcas-
pases and thus enhances the induction of apoptosis and antipro-
liferative effects of antineoplastic pharmacotherapeutics (Arnt
et al., 2002); continued studies have strengthened the application
of this peptide in vivo (Fulda et al., 2002).
The past decade has witnessed an escalating interest in the
therapeutic applications of CPPs (Derossi et al., 1994). Alterna-
tively designated protein transduction domains, CPPs, have
demonstrated utility as vectors for the highly efficient delivery
of bioactive cargoes into the intracellular milieu (Langel, 2007).
Derived from either endogenous proteins (e.g., penetratins; Der-
ossi et al., 1994) or entirely synthetic in nature (e.g., Model
Amphipathic Petide (MAP) sequences; Lindgren et al., 2000),
a vast majority of CPPs are polycationic or amphipathic and so
comprise multiple Arg and/or Lys residues that confer cell pene-
trating properties. The majority of studies to date have employed
sychnologically organized combinations (Portoghese, 1989) of
a cargo (message) and a CPP (address) joined as a tandem
construct. Bioactive cargoes have included peptides, proteins,
cytotoxins, and oligonucleotides including short interfering
RNA and peptide nucleic acids (Langel, 2007; Schwarze and
Dowdy, 2000). Moreover, CPPs also improve the intracellular
delivery of larger moieties such as liposomes when assembled
as noncovalent complexes (Tseng et al., 2002).
More recently, a QSAR-based algorithm has been developed
to predict cryptic polycationic CPP motifs within the primary
sequences of proteins (Ha¨llbrink et al., 2005). Moreover, Arg,735–744, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 735
Figure 1. Cryptic CPP Sequences of Cyt c
(A) Quaternary structure of Cyt c and the restricted
distribution of cryptic CPP sequences. Highly
probable CPPs are located in the amino and
carboxyl termini.
(B) Peptide sequences and abbreviations of
cryptic CPP and other peptides used in this study.
Vertical lines indicate a disulphide bridge.
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interfaces. Hence, we considered it very likely that some cryptic
CPP sequences within the primary sequences of key signaling
proteins should have intrinsic biological activity. Moreover, the
identification of proteomimetic CPPs, in which multiple pharma-
cophores for cellular penetration and biological activities are
presumed to be discontinuously (rhegnylogically) organized
within the primary sequence (Portoghese, 1989), would repre-
sent a new class of biological agent.
Themajor aimof this studywas to employ humancytochrome c
(Cyt c) as a prediction template to enable the identification of
CPPs that can mimic the trafficking events and apoptogenic
activity of the native protein. This investigation also provided
a rigorous assessment of the utility of the prediction algorithm to
identify new CPP sequences. Having identified a range of CPPs,736 Chemistry & Biology 17, 735–744, July 30, 2010 ª2010 Elsevier Ltd All rights reservedone peptide,with an enhancedpropensity
for cellular penetration, was selected for
further development as a chimeric apop-
togenic agent that targets components
of thenuclearporecomplex (NPC), specif-
ically the FG nucleoporins (FG Nups), as
a novel therapeutic strategy. Character-
ized by multiple FXFG repeat sequences,
FG Nups regulate import and export
between the cytoplasm and the nucleus.
Nup153 was the target protein of choice
since it is one of the most characterized
of the FG Nups and assumes roles in
nuclear import and the regulation of pore
selectivity, nuclear basket formation,
nuclear pore complex anchoring and
nuclear envelope breakdown (Walther
et al., 2001; Prunuske et al., 2006).
RESULTS
Human Cyt c as a CPP Prediction
Template: Distribution of Predicted
CPPs within the Human Cyt c
Protein
Human Cyt c (Figure 1A), a highly
conserved 10 aa protein, has well-
documented dual roles in mitochondrial
electron transport and intrinsic apoptotic
events (Jiang and Wang, 2004). This
study was, therefore, primarily designed
to address the fundamental question of
whether cell penetrating fragments of
Cyt c could mimic the apoptogenicactivity of the native protein. Using the QSAR-based prediction
algorithm (Ha¨llbrink et al., 2005) to delineate putative CPPs
within the primary sequences of Cyt c, peptides were ranked
from 1 (lowest probability) to 3 (highest probability). We chose
to focus our efforts entirely on highly probable CPP sequences
(Figure 1A). Furthermore, an extended range of Cyt c-derived
peptides was included in these studies to provide both a more
rigorous assessment of this general strategy and to supplement
previous investigations limited to Cyt c77–101 and Cyt c86–101
(Howl and Jones, 2008) (Figure 1B).
As indicated in Figure 1A, QSAR analysis of human Cyt c
identified 31 highly probable CPPs of which 25 were derived
from the larger carboxyl-terminal helix. Predicted CPPs within
the size range of 5–25 aa were entirely restricted in topological
distribution to the two major helical domains, closely associated
Figure 2. Translocation Efficacies and Predictions of Secondary
Structure of Cyt c-Derived CPPs
(A) Translocation efficacies. U373MG cells were incubated with fluorescently
labeled peptides (5 mM) for 1 hr at 37C. Cell lysates were analyzed by fluores-
cence spectroscopy and results expressed as fold/basal fluorescence from
three experiments performed in triplicate.
(B) Helical wheel projections of highly penetrant peptides derived from Cyt c.
The well-characterized CPP penetratin and mitP have been included for
comparison. Projections show the distribution of cationic charge (shaded
amino acids). Diagrams were produced using the helical wheel interactive
Java Applet (http://kael.net/helical.htm). X denotes the known helix promoter
a- aminoisobuytyric acid (Aib).
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termini of the protein (Figure 1A).
Comparative Translocation Efficacies of Cyt c-Derived
CPP
As indicated in Figure 2A, CPPs derived from Cyt c exhibited
a large dynamic range of translocation efficacies. As previously
reported (Howl and Jones, 2008), and despite the relatively lowChemistry & Biology 17,translocation efficacy indicated here (Figure 2A), Cyt c86–101
can be observed specifically located within the nucleus of
U373MG cells (Table 1). These comparative data further indicate
that, of all Cyt c-derived CPPs included in this study, Cyt c77–101
is a very efficient CPP (105.9 ± 0.42-fold uptake).
The well-characterized CPP penetratin was also included in
this quantitative analysis of intracellular uptake and demon-
strated a 591.3 ± 37.52-fold uptake. Comparative investigations
also included the mitochondriotoxic CPP mitoparan (mitP)
(Jones et al., 2008) that, as demonstrated in Figure 2A, gave
a 1455.8 ± 13.8-fold uptake. MitP is a peptide analog of the
ahelical amphipathic tetradecapeptide mastoparan and was
designed to incorporate sequence permutations that enhanced
amphipathicity by introducing additional cationic charge within
the hydrophilic face of mastoparan (Jones and Howl, 2004). As
indicated by predictions in secondary structure (Figure 2B),
mitP presents six positive charges, 5 lysyl 3-amino groups, and
the amino terminus of Ile, within its hydrophilic face. Given that
mitP also demonstrates an enhanced propensity for cellular
penetration and that amphipathic sequences are more likely to
be cell penetrant, predictions in secondary structure were
carried out to ascertain whether other highly penetrant
sequences in this study shared the same biochemical traits.
Figure 2B demonstrates that while mitP clearly shows a marked
delineation between its hydrophobic and hydrophilic faces, such
a patent dichotomy is not apparent within other designated
highly penetrant cationic CPP.
Biological Profiles of Cryptic CPP Derived from Cyt c
Having identified a range of CPPs, and given that Cyt c is a key
regulator of programmed cell death, each sequence was evalu-
ated for its ability to induce apoptosis alongside establishment of
intracellular distribution. U373MG astrocytoma was used as
a model cell line since it is well characterized and used in our
laboratory to examine apoptotic events. Both Cyt c77–101 and
Cyt c86–101 specifically induced apoptosis, as was confirmed
by TUNEL assay in situ and activation of caspase-3 (Table 1),
though changes in cellular viability measured byMTT conversion
demonstrated only moderate potencies for Cyt c86–101 and Cyt
c77–101, with LD50 values of 51.42 and 80.63 mM, respectively.
Other cryptic peptides presented in Table 1 were excluded
from further study owing to their inability to reduce cellular
viability at physiologically acceptable concentrations.
Live confocal cell imaging indicated that Cyt c77–101 and the
shorter homolog Cyt c86–101 translocated U373MG plasma
membranes to differentially accumulate in extranuclear or
nuclear compartments, respectively (Table 1) (Howl and Jones,
2008). More specifically, quantitative colocalization analyses
demonstrated that Cyt c77–101 strongly colocalized with the
endoplasmic reticulum (ER) and gave a colocalization coefficient
of 0.996 ± 0.002.
Selection of Nup153980–987 As a Nuclear Pore-Targeting
Motif
Thehighly cell penetrant yetmoderately apoptogenic peptideCyt
c77–101 was selected for further development as a chimeric apop-
togenic agent. This chimeric strategy was largely pursued in the
light of our recent developments with the mitochondriotoxic
CPP mitP and its highly potent target-selective analogs (Jones735–744, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 737
Table 1. Biological Profiles of CPP Derived from Cyt c
Peptide LD50 Intracellular Target Apoptosis
Cyt c86–101 51.42 mM Nucleus TUNEL positive
Caspase-3 positive
Cyt c77–101 80.63 mM Endoplasmic
reticulum
TUNEL positive
Caspase-3 positive
Nup153-
Cyt c77–101
0.73 mM Perinuclear TUNEL positive
Caspase-3 positive
scrNup153-
Cyt c77–101
Not toxic Cytoplasmic Not toxic
Cyt c79–92 >200 mM Discontinued from this study due to their
low translocation efficacies and inability
to induce apoptosis
Cyt c79–88 >200 mM
Cyt c4–13 >200 mM
Cyt c5–13 >200 mM
LD50 values represent the concentration of peptides required to induce
apoptotic death of 50%of cultured U373MG cells. The intracellular target
was determined by confocal microscopy of living cells and reports the
propensity of different peptides to accumulate in various intracellular
compartments. Where indicated, apoptosis has been confirmed by
a combination of both TUNEL staining and caspase-3 activity.
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enhance cytotoxicity and/or develop target-selective drug
delivery vectors that combined both an apoptogenic CPP and
a bioactive peptidyl motif. The apoptogenic potency of Cyt
c77–101 was most significantly enhanced by chimeric N-terminal
extension with a sequence derived from the C-terminal of nucle-
oprorin 153 (Nup153) (Figure 1B). The nonapeptide sequence
Nup153980–987 (NNFKFGLSS) contains the common tetrameric
FXFG repeat that, in approximately one-third of nucleoporin
proteins, mediates binding to transport receptors including
importin b (Bednenko et al., 2003). Sequence design was also
based on there being 15 FXFG repeat sequences throughout
theNup153protein, 4ofwhichareFKFG,while numerous viscinal
serines appear throughout.
We included this sequence, acetylated at the amino terminus
to inhibit proteolysis, as a sychnologically organized amino-
terminal extension of Cyt c77–101 in the chimeric construct
Ac-Nup153980–987(Ahx)Cyt c77–101 (Nup153-Cyt c) (Figure 1B).
A similar construct with a scrambled Nup153 sequence
(scrNup153-Cyt c) (Figure 1B) was also included in cytotoxicity,
translocation, and subcellular localization studies to confirm
the specific bioactivity of the Nup153-derived FXFG-containing
nonapeptide.
Characterization of Nup153-Cyt c As a Potent
Apotogenic Chimera
N-terminal extension of Cyt c77–101 with Nup153980–987 signifi-
cantly enhanced the cytotoxic potency of Cyt c77–101. Thus,
the chimeric construct Nup153-Cyt c induced apoptosis of
U373MG astrocytoma with an LD50 of 0.73 mM, a concen-
tration readily achieved in vivo, whereas the scrambled
sequence scrNup153-Cyt c (Ac-GFSNSFKLN(Ahx)Cytc77–101)
and Nup153980–987 alone were inactive (Figure 3A; Table 1). Apo-
ptosis was confirmed as the mechanism of cell death and was
demonstrated by the peptide’s ability to activate caspase-3
and induce internucleosomal DNA fragmentation (Figures 3B
and 3C). Furthermore, the translocation efficacies of both738 Chemistry & Biology 17, 735–744, July 30, 2010 ª2010 Elsevier LNup153-Cyt c (408.2 ± 15.58-fold) and the biologically inactive
scrambled construct scrNup153-Cyt c (412.5 ± 5.20-fold) were
enhanced compared to the native peptide Cyt c77–101 (105.9 ±
0.42-fold) (Figure 2A). These data therefore suggest specificity
of action for an intracelluar target by Nup153-Cyt c in the orches-
tration of apoptosis.
Nup153-Cyt c As a Novel Apoptogenic CPP
and Its Mechanism of Action
To decipher the mechanism by which Nup153-Cyt c induced
apoptotic events, Nup153980–987 was translocated into
U373MGcells by the inertCPPM918asafluorescein-conjugated
disulphide-linked cargo H-CNFKGLSSK(N3-5,6-carboxyfluores-
cein)-NH2 (Fluo-Nup153
980–987) (Figure 1B). Fluo-Nup153980–987
demonstrated a distinct accumulation around the nuclear
periphery (Figure 4A). Complementary studies were performed
using the rhodamine-labeled chimeric structures Rho-Nup153-
Cyt c and the control peptide Rho-scrNup153-Cyt c. Confocal
live cell imaging indicated that Rho-Nup153-Cyt c assumed
a predominant perinuclear localization after 45min of administra-
tion, whereas Rho-scrNup153-Cyt c displayed a more general-
ized cytoplasmic distribution at a similar time point (Figure 4B).
To further refine these early events, U373MG cells were treated
with either Rho-Nup153-Cyt c or Rho-scrNup153-Cyt c for 45
min and the nucleoporin protein Nup153 detected by immunos-
taining (Figure 4B). Quantitative colocalization analysis demon-
strated that Rho-Nup153-Cyt c assumed a strong colocalization
with Nup153 (coloc coefficient = 0.93 ± 0.024) comparedwith the
diffusely distributed scrambled chimera (coloc coefficient =
0.157 ± 0.031) (p < 0.0001, unpaired t test, two-tailed).
Given the subcellular localizations of Fluo-Nup153980–987 and
Rho-Nup153-Cyt c, additional studies were performed to estab-
lish whether intracellular Nup153-Cyt c directly modulated the
functional utility of the nuclear pore complex. Later events at
4 hr, analyzed using indirect immunofluorescence, demon-
strated that Nup153-Cyt c facilitated the dramatic redistribution
of the NPC protein Nup153 from the nuclear periphery to the
nucleoplasm and cytoplasm (Figure 4D). Moreover, this reloca-
tion phenomenon was similarly observed in the presence of
the pan-caspase inhibitor Q-VD-OPh and indicates that the
redistribution of Nup153 in Nup153-Cyt c-treated cells is not
a downstream consequence of caspase activation (Figure 4D).
Significantly, the intracellular delivery of Nup153980–987, using
either of the inert CPPs penetratin or M918, induced only
moderate reductions in cellular viability (Figure 5) indicating
that the apoptogenic properties of the chimeric peptide
Nup153-Cyt cmay in part be attributable to the peptide targeting
additional intracellular sites, besides that of the nuclear pore
complex. In light of these findings and given that the parent
peptide Cyt c77–101 demonstrates a strong propensity for coloc-
alization (coloc coefficient = 0.996 ± 0.002) with the ER (Table 1),
quantitative colocalization analysis with ER was performed with
both Rho-Nup153-Cyt c and its scrambled analog. Both
peptides gave a considerably low level of colocalization with
coloc coefficients of 0.287 ± 0.065 and 0.354 ± 0.063, respec-
tively. Thus, the enhanced apoptogenic potency demonstrated
by Nup153-Cyt c may not be attributed to interaction with the
ER. This line of investigation was pursued in the light of recent
reports that native Cyt c binds inositol 1,4,5-trisphosphatetd All rights reserved
Figure 3. Characterization of Nup153-Cyt c as a Potent Apoptogenic Chimera
(A) N-terminal extension of Cyt c77–101 with Nup153980–987 significantly enhances the cytotoxic potency of Cyt c77–101, while Nup153980–987 and the scrambled
sequence chimera scrNup153-Cyt c are inactive. U373MG cells were exposed to increasing concentrations of peptides (0.001–30 mM) for 24 hr. Cell viability
was measured by MTT conversion and expressed as a percentage of those cells treated with vehicle (medium) alone. Data points are mean ± SEM from three
experiments performed in sextruplicate.
(B) Nup153-Cyt c induces apoptosis of U373MG astrocytoma as confirmed by activation of caspase-3. U373MG cells were treated with Nup153-Cyt c at the
concentrations indicated for 4 hr. DEVD-NucView 488 caspase-3 substrate (Biotum, Inc.) was added at a final concentration of 5 mM for a further 30 min and
cells were viewed by confocal live cell imaging. The cell permeable construct DEVD-NucViewTM 488 caspase-3 substrate consists of a functional high affinity
DNA-binding dye that is rendered inert by the highly negatively charged DEVD peptide substrate. Upon activation of caspase-3, the substrate is cleaved to
release a functional DNA dye that subsequently migrates to the nucleus. Green fluorescence seen in the nuclei of Nup153-Cyt c-treated cells indicates activation
of caspase-3, compared with cells treated with medium alone (vehicle) or treated cells incubated with the caspase-3 inhibitor Ac-DEVD-CHO (25 mM).
(C) Nup153-Cyt c induces apoptosis of U373MG astrocytoma as confirmed by nuclear DNA fragmentation. U373MG cells were treated with Nup153-Cyt c, at the
concentrations indicated or with vehicle alone for 18 hr. Cells were fixed in 4% (w/v) formaldehyde and permeabilized with 0.1% (v/v) Triton X-100. Nuclear DNA
fragmentation was detected by TUNEL in situ cell detection assay TMR red (Roche), and cells were counterstained with DAPI to visualize nuclear DNA. Repre-
sentative examples are shown. The appearance of TMR red fluorescence located in the nuclei of Nup153-Cyt c-treated cells provides evidence of apoptosis,
whereas DNA fragmentation is not evident in cells treated with vehicle alone (vehicle). Fixed and permeabilized cells were incubated with DNase I
(3000 U/ml) to induce DNA strand breaks, prior to the labeling procedure and therefore acts as a positive control (DNase I). DNA fragmentation is comparable
to cells treated with Nup153-Cyt c. As a negative control, fixed and permeabilized cells were treated with labeling solution without terminal deoxynucleotidyl
transferase (-Tdt).
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Figure 4. Nup153-Cyt c: Intracellular Distribution, Colocalization,
and Redistribution of Nucleoporin 153
(A) Nup153 translocates to the nuclear periphery (early events). Fluo-
Nup153980–987 is liberated from Fluo-Nup153-M918 (Table 1) following cellular
penetration and a subsequent intracellular reduction of cysteine. Fluo-
Nup153980–987 shown here in green now assumes a peripheral nuclear distri-
bution. U373MG were treated with 5 mM Fluo-Nup153-M918 for 1 hr and
visualized by live confocal cell imaging.
(B) U373MG cells were subsequently treated with either Rho-Nup153-Cyt c
(3 mM) or the scrambled control peptide Rho-scr-Nup153-Cyt c (3 mM) and
analyzed by live confocal cell imaging. After 45 min, Rho-Nup153-Cyt c
assumed a predominant perinuclear distribution (i), whereas Rho-
scrNup153-Cyt c adopted a more generalized cytoplasmic distribution (ii).
Cellular distributions of peptides for (A) and (B) are presented here merged
with images taken under differential interference contrast microscopy and
assist in highlighting the nucleus.
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740 Chemistry & Biology 17, 735–744, July 30, 2010 ª2010 Elsevier Lreceptors (IP3R) located on the ER to amplify apoptotic-signaling
events (Boehning et al., 2003).DISCUSSION
Proteomimetic CPPs
Amajor aim of this study was to employ QSAR analysis of human
Cyt c to identify cell penetrant sequences that can mimic the
apoptogenic activity and trafficking events of the native protein.
The distribution of highly probable CPPs within the Cyt c primary
sequence was restricted to the closely paired N- and C-terminal
helical domains that are a highly conserved structural motif. Two
such sequences, Cyt c77–101 and the shorter homolog Cyt
c86–101, translocate the plasma membrane to differentially accu-
mulate in extranuclear (ER) or nuclear compartments, respec-
tively. Moreover, these peptides also induce apoptosis in brain
tumor cells, indicating that they mimic the role of Cyt c as
a key regulator of apoptsis. Thus, these and other sequences
contain both cell penetrating (address) and biologically active
(message) pharmacophores that are discontinuously organized
within a rhengnylogic peptide.
We also hypothesize that these helical sequences may
constitute integral transduction or binding domains within Cyt c
that enable the protein to interact with plasma, ER, and nuclear
membranes. Moreover, the multifunctional roles of Cyt c require
interaction with various biological membranes or targets. When
released from mitochondria, cytosolic Cyt c not only triggers
apoptosis by forming the apoptosome, a multimeric complex
composedof Apaf-1 and caspase-9, but also accumulateswithin
the nucleus to partake in chromatin remodelling (Nur-E-Kamal
et al., 2004). Furthermore, cytosolic Cyt c binds to ER-located
IP3Rs to attenuate inositol 1,4,5-trisphosphate (IP3)-mediated
inhibition of calcium release (Boehning et al., 2003). Inhibition of
this negative feedback drives a feed forward mechanism that
sustains release of ER-derived calcium which in turn augments
calcium accumulation within mitochondria with a consequential
enhancement in mitochondrial membrane permeability and
further release of Cyt c. Recent studies would also indicate that
Cyt c internalizes into living cells (Howl and Jones, 2008), while
the protein is also reported to play an extracellular role in inflam-
matory pathologies (Pullerits et al., 2005). Given the propensity of
Cytc tomove frommitochondria to nucleus, ER, intracellular, and
extracellular compartments, it is perhaps not surprising that(C) Colocalization of Rho-Nup153-Cyt c with nucleoporin 153 (Nup153),
(early events). U373MG cells were incubated for 45 min with Rho-Nup153-
Cyt c (3 mM) or scrambled control. Fixed and permeabilized cells were immu-
nostained for the nucleoporin protein Nup153 and viewed by confocal
microscopy. Cells were counterstained with DAPI to visualize the nuclear DNA.
(D) Nup153-Cyt c elicits redistribution of Nup153 in U373MGcells (later events).
Under control conditions, Nup153 resides in the nuclear periphery to face the
nucleoplasm and can be visualized by predominant staining of the nuclear
periphery (i). Following treatment with Nup153-Cyt c, Nup153 assumes a more
diffuse pattern and redistributes to the nucleoplasm and cytoplasm (ii).
U373MGcellswere treated for 4 hrwithNup153-Cyt c (3mM)or vehicle (medium
alone). Treated cells were also coincubated with the pan-caspase inhibitor
Q-VD-OPh (20 mM) (iii). Redistribution of Nup153 is still observed. Fixed cells
were probed with primary (sheep polyclonal Anti-Nup153) and secondary
(anti-sheep IgG conjugated to FITC) antibodies and visualized by confocal
microscopy. Cells were counterstained with DAPI to visualize the nucleus.
td All rights reserved
Figure 5. Intracellular Delivery of Nup153980–987 Using Biologically
Inert CPPs
U373MG cells were exposed to increasing concentrations of peptides (0.001–
30 mM) for 24 hr. Cell viability wasmeasured byMTT conversion and expressed
as a percentage of those cells treated with vehicle (medium) alone. Data points
are mean ± SEM from three experiments performed in sextruplicate.
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organelles and milieu as discussed below.
Besides data presented herein, there are few yet growing
reports of CPP prediction which have identified intrinsically bio-
logically active CPP. QSAR analysis has identified CPP from the
intracellular loops of G protein-coupled receptors that mimic the
agonist-activated receptor. More specifically, a peptide derived
from the C-terminal intracellular sequence of the rat angiotensin
receptor (AT1a) internalizes into living cells and elicits blood
vessel contraction, while a peptide derived from the human
glucagon-like peptide receptor (GLP-1R) induces insulin
release from isolated pancreatic islets (O¨stlund et al., 2005).
Similarly, we have identified a 20 amino acid cell penetrant
fragment within the human type (a) calcitonin receptor
(hCTR(a)), hCTR(a)174–193. Derived from the first intracellular loop,
hCTR(a)174–193 is an independent stimulator of CAMP formation
and also demonstrates a direct activation of heterotrimeric G
proteins, as was measured by the initial rate of binding of [35S]
GTPgS to rat brain cortical membranes (Jones et al., 2006).
Though not originating from QSAR analysis, Johansson et al.
(2008) have identified a cell permeable 22 amino acid peptide
that corresponds to the N-terminal of p14ARF that inhibits the
proliferative propensity of breast cancer cells. It is therefore
most probable that CPP prediction will identify further cell pene-
trant proteomimetic peptides that can modulate key events in
cell biology and pathology. Though we may not claim that
such predictions are infallible (Hansen et al., 2008), QSAR-
based analysis of probable CPP within signal transduction
modulatory proteins is nevertheless a promising starting point.Chemistry & Biology 17,Translocation Efficacies of Proteomimetic CPP
The peptide that demonstrated the greatest degree of cellular
penetration was the comparative control peptide mitP (1455.8 ±
13.8-fold uptake). Accordingly, using both helical wheel predic-
tions in secondary structure and hydropathicity indices, this
peptide was predicted to be strongly amphipathic (HF = 0.49).
However, a presumed amphipathic secondary structure can not
purely account for enhanced cellular penetration since the hydro-
pathicity value for penetratin (HF = 1.731) suggests a lesser
degree of amphipathicity compared with all other Cyt c-derived
peptides, yet penetratin displays a higher degree of cellular pene-
tration (591.3 ± 37.52-fold uptake) (Figure 2). Similarly, the
chimeric structures Nup153-Cyt c (HF = 0.336) and
scrNup153-Cyt c (HF = 0.336) and Cyt c77–101 (HF = 0.317)
alone present similar hydropathicity values and are thus predicted
to share the same degree of amphipathicity. However, the
chimeric structures Nup153-Cyt c (408.2 ± 15.58-fold uptake)
and scrNup153-Cyt c (412.5 ± 5.20-fold uptake) demonstrate an
enhanced propensity for cellular penetration compared to Cyt
c77–101 (105.9 ± 0.42-fold uptake). It is therefore more likely that
increased cationic charge provided by Lys4 of the N-terminal
extension Nup153980–987 is accountable for this observation.
Nup153-Cyt c: Intracellular Targets and Biological
Mechanisms of Action
Owing to its strong propensity for cellular penetration and
moderate apoptogenic activity, Cyt c77–101 was selected for
further modification and development as a chimeric apoptogenic
agent. Indeed, the apoptogenic potency of Cyt c77–101 was most
significantly enhanced by N-terminal extension with the peptide
Nup153980–987, a sequence derived from Nup153 and designed
to target the NPC as a novel therapeutic strategy. Moreover, at
earlier time points (45 min) Rho-Nup153-Cyt c assumes a
predominant perinuclear distribution and more specifically,
a strong colocalization with the protein Nup153. Suggested bio-
logical mechanisms underlying the apoptogenic potency of
Nup153-Cyt c becamemore apparent following 4 hr of treatment
with the peptide, principally, the diffuse redistribution of the NPC
protein Nup153 from the nuclear periphery to the nucleoplasm
and the cytoplasm. These data suggest that Nup153-Cyt c
may modulate the control of nuclear transport events or indeed
the functional utility of the NPC.
However, reduced cytotoxic potencies (moderate reductions
in cellular viability) were observed following the intracellular
delivery of Nup153980–987 using either the inert CPP penetratin
or M918. This observation coupled with a distinct perinuclear
distribution of Nup153980–987 when delivered into cells by
M918 would indicate that Nup153-Cyt c targets additional intra-
cellular compartments besides that of the nuclear pore complex
in the orchestration of apoptotic events. It was initially postulated
that the synergistic effect of Nup153-Cyt cmay be attributable to
this peptide chimera also interacting with IP3Rs located within
the ER. The following lines of evidence would support such
a hypothesis (1) Cyt c77–101 demonstrates a strong propensity
for coloalization with ER (coloc coefficient = 0.996 ± 0.002) and
(2) as mentioned previously, during early apoptotic events, the
release of mitochondrial Cyt c modulates the function of IP3Rs
with a resultant augmentation in oscillatory calcium transients.
This feed forward mechanism augments further Cyt c release735–744, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 741
Figure 6. Modular Representation of
Peptidyl Tumour Homing Constructs
CPP conjugation enhances the bioavailabilty of
apoptogenic moities (Myrberg et al., 2008) and
inclusion of THPs ensures a directed specific
targeting to tumor cells, their vasculature, or
lympahtics (Enba¨ck and Laakkonen, 2007). How-
ever, somewhat difficult conjugation steps
between CPPs and apoptogenic pharmacothera-
peutics can be circumvented by the use of apop-
togenic CPPs which possess the dual features of
cellular penetration and biological activity.
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notably, the region of the IP3R to which Cyt c binds is dependent
upon a cluster of glutamic acid residues within the C-terminal of
the channel (Boehning et al., 2005). It is thus not implausible that
the highly basic Cyt c77–101 peptide encompasses the interaction
domain which coordinates Cyt c binding to IP3Rs through elec-
trostatic interactions. However, while this mechanism could
account for the moderately apoptogenic features of Cyt c77–101
alone, data presented herein indicate a poor colocalization of
the chimeric construct Nup153-Cyt cwith ER (coloc coefficient =
0.287 ± 0.065) and emphasize a strong colocalization with
Nup153 (coloc coefficient = 0.93 ± 0.024).
Moreover, and as previously alluded to, the multifunctional
roles of Cyt c require the protein to translocate numerous biolog-
ical membranes including the cytoplasmic-nuclear interface. Cyt
c translocates to the nucleus to partake in chromatin remodeling
(Nur-E-Kamal et al., 2004) and apoptotic cells show perinuclear
Cyt c aggregation (Ruiz-Vela et al., 2002). Thus, Cyt c77–101 may
very well posses a nuclear translocation sequence/integral
transduction domain, whichmay facilitate the targeting /incorpo-
ration of Nup153-Cyt c to the NPC.
It is noteworthy that the apoptogenic features of Cyt c77–101
are not likely to be attributable to apoptosome formation since
Cyt c77–101 does not encompass the domain/amino acids
required for apoptosome activation. Notably, alanine substitu-
tion of Lys72 of Cyt c fails to oligomerize with Apaf-1
(Hao et al., 2005). Furthermore, unpublished data from studies
using isolated mitochondria demonstrate that Cyt c77–101 fails
to elicit mitochondrial matrix swelling and permeabilisation of
inner mitochondrial membranes. Thus, the apoptogenic mecha-
nism employed by Cyt c77–101 is unlikely to necessitate direct
release of endogenous mitochondrial Cyt c.
Endosomal entrapment with a consequential reduction in bio-
logical efficacy is in some cases, problematic when utilizing CPP
for intracellular cargo delivery. This phenomenon largely
depends upon the specific CPP and/or the cargo of interest
and is therefore by no means predictable (Ra¨a¨gel et al., 2009).
Accordingly, the high potency exhibited by Nup153-Cyt c may
be attributable in part to the presented proteomimetic Cyt c
peptides escaping endosomal entrapment, as is demonstrated
by their ability to specifically accumulate at distinct intracellular
localizations.
Utility of Apoptogenic CPP and the Cell-Specific
Induction of Apoptosis
Nup153-Cyt c demonstrates potential as a potent inducer of
apoptosis. Moreover, unlike extensively processed apotogenic742 Chemistry & Biology 17, 735–744, July 30, 2010 ª2010 Elsevier Lpharmaceuticals where every potential modification site is
a pharmacophore, CPPs more easily afford the incorporation
of homing peptides. Thus, the inclusion of homing sequences
which recognize markers expressed or overexpressed on tumor
cells could ensure a directed therapeutic induction of apoptosis
while sparing healthy tissue. Such tumor homing peptide (THP)
sequences are now being identified through phage display tech-
nologies (Enba¨ck and Laakkonen, 2007) and can be part of
a modular framework for the design of tumor-specific apopto-
genic constructs as presented below (Figure 6).
SIGNIFICANCE
The molecular properties of the two Cyt c-derived peptides,
Cyt c77–101 and Cyt c 86–101, peptides that are both cell pene-
trating and apoptogenic clearly demonstrate that the
prediction of CPP can also identify rhegnylogically orga-
nized proteomimetics. Furthermore, the novel chimeric
construct Nup153-Cyt c, derived by N-terminal extension
of Cyt c77–101, demonstrates potential as a potent inducer
of apoptosis and further propounds the nuclear pore
complex as a novel target for the therapeutic induction of
apoptosis. Moreover, while CPP are emerging as promising
candidates for future drug delivery, owing to their ability to
improve cellular uptake, thus enhancing bioavailability,
CPP with specific biological activity carry the additional
bonus of simplifying often complex conjugation steps.
Indeed, proteomimetic CPP may easily be incorporated
into constructs with peptidyl address motifs, the latter of
which could enhance the selectivity of drug delivery leading
to a probable reduction in nonselective side effects.
EXPERIMENTAL PROCEDURES
Prediction of CPP
As previously described (Ha¨llbrink et al., 2005), QSAR analyses can be used to
identify putative CPPs within the primary sequence of proteins. We employed
this method to assess the averaged bulk property values of amino acids within
a sequence of Cyt c (5–30 amino acids in length) and compared these with
defined values obtained from a training set of 24 CPP and 17 nonpenetrant
analogs.
Peptide Synthesis, Purification, and Analysis
A majority of the peptides utilized in this study were manually synthesized
(0.1–0.2 mmol scale) on Rink amide methylbenzhydrylamine (MBHA) resin
(Novabiochem, Beeston, UK) employing an N-a-Fmoc protection strategy
with O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate
(HBTU, Novabiochem)) or O-(6-Chloro-1-hydrocibenzotriazol-1-yl)- 1,1,3,3-
tetramethyluronium hexafluorophosphate (HCTU; AGTC Bioproducts, Hessle,td All rights reserved
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CGPPRVRV-NH2) and the cargo H-CNFKFGLSSK(N
3-5,6-carboxy-flourescein)-
NH2 (fluorNup153) (Table 1) were synthesized on an Applied Biosystems
model 433A synthesizer using t-Boc chemistry as recently reported
(El-Andaloussi et al., 2007). To facilitate conjugation, equimolar amounts of
M918 with an amino-terminal Cys(3-nitro-2-pyridinesulfanyl) and H-CNF
KFGLSSK(N3-5,6-carboxy-flourescein)-NH2 were solvated in a mixture of
250 ml dimethylformamide (DMF) and 250 ml 50 mM acetic acid buffer
(pH 5.0). The solution was purged with N2 for 4 min followed by 4 hr incubation
while mixing the contents continuously.
All other fluorescent peptides, to be used in confocal live cell imaging and
quantitative uptake analyses, were synthesized by amino-terminal acylation
of CPP sequences with 6-carboxy-tetramethylrhodamine (Novabiochem,
Beeston, UK) as reported previously (Jones et al., 2008). Crude peptides
were purified to apparent homogeneity by semipreparative scale high-perfor-
mance liquid chromatography (Jones et al., 2008; El-Andaloussi et al., 2007).
The predicted masses of all peptides used (averageM + H+) were confirmed to
an accuracy of ± 1 by matrix-assisted laser desorption ionization (MALDI) time
of flight MS operated in positive ion mode using a-cyano-4-hydroxycinnamic
acid (Sigma) as a matrix.
Cell Culture
U373MG human astrocytoma cells were routinely maintained in a humidified
atmosphere of 5% CO2 at 37
C in DMEM supplemented with L-glutamine
(0.1 mg/ml) 10% (w/v) fetal bovine serum (FBS), penicillin (100 U/ml), and
streptomycin (100 mg/ml).
Quantitative Analyses of Peptide Translocation
U373MGcellswere culturedasabove, transferred to25cm2 tissueculture flasks
and grown to 75% confluence. Immediately prior to the addition of fluorescent
peptides, cellswerewashedwith and transferred into 2ml of stimulationmedium
(SM; DMEMwithout phenol red). Cells were incubated with fluorescent peptides
at a final concentration of 5 mM for 1 hr in SMat 37C in a humidified atmosphere
of 5% CO2. Cells were then washed once in Hanks Balance Salt Solution, three
times SM, and detached with 400 ml of 1% trypsin at 37C. Cells were collected
by centrifugation from800ml ofSMandpellets lysed in 450ml 0.1MNaOH for 2 hr
on ice. Samples (200 ml) of cell lysates were mixed with 300 ml of 0.1 M NaOH,
transferred to a 1ml quartz cuvette, and analyzed using aHitachi F-2500 fluores-
cence spectrophotometer (lAbs 552nm/lEm 580 nm).
Confocal microscopy
Live Cell Imaging Analysis
U373MG cells were transferred to 35 mm sterile glass base dishes (IWAKI,
Japan) and grown to 75% confluence (conditions as described above). Imme-
diately prior to the addition of fluorescent peptides and/or othermaterials, cells
were washed with and transferred into SM. During the period of exposure to
peptides, cell layers were maintained at 37C in a humidified atmosphere of
5% CO2. Immediately prior to observation, cells were then washed gently
with SM (83) and analyzed with a Carl Zeiss LSM510Meta confocal micro-
scope equipped with a live cell imaging chamber.
Quantitative Colocalization
For ER colocalization studies, cells were incubated with 1 mM ERTracker
Green FM (Molecular Probes, Invitrogen, Paisley, UK) alongside fluorescent
peptides and viewed by live confocal cell imaging. For Nup153 colocalization
studies, U373MG cells were grown to 75% confluence on coverslips in six-
well plates, washed, and treated with 3 mM peptides for 45 min. Cells were
washed with phosphate-buffered saline (PBS; pH 7.4) and fixed with cold
methanol:acetone (1:1, v/v) for 10 min on ice. To remove fixative cells were
washed x 3 in PBS, then blocked with 1% (v/v) FBS in PBS for 30 min at
room temperature. Washed cells were allowed to air dry and then were incu-
bated with primary sheep anti-human, anti-Nup153 antibody (ImmuQuest) for
1 hr at room temperature in the dark. Cells were washed five times with PBS
and incubated with secondary antibody (1:100), rabbit anti-sheep IgG conju-
gated to FITC (Sigma) for a further 1 hr at room temperature in the dark. Cover-
slips were washed in PBS, air-dried, and mounted on slides with Vectashield
(Vector Laboratories Inc., Peterborough, UK) containing 4060 diamidino-8-phe-
nylindole dihydrochloride (DAPI) to counterstain double-stranded DNA.Chemistry & Biology 17,Quantitative colocalization was performed using the Carl Zeiss quantitative
colocalization analysis software, incorporating an interactive scatter plot and
data table linked to the images. Pixels showing an intensity above the back-
ground of both channels (background defined as, pixels in channel 1 only,
e.g., rhodamine and pixels in channel 2 only, e.g., fluorescein) were designated
as colocalized pixels. Data were collected from an average of 12 regions of
interest, between 50 and 200 mm2 and from three independent experiments.
Colocalization (coloc) coefficients were calculated for the two different fluoro-
phores according to the following equations: C1 = pixels channel 1 coloc/pix-
els channel 1 total, C2 = pixels channel 2 coloc/pixels channel 2 total and
defined as relative number of colocalizing pixels in channel 1(designated
rhodamine) or 2 (designated fluorescein), respectively, as compared with the
total number of pixels above threshold. Coefficients generated values between
0 and 1. A value of 0 indicated no colocalization, whereas a value of 1 indicated
that all pixels were colocalized.
Redistribution of Nup153
U373MG cells were grown to 75% confluence on coverslips in six-well plates,
washed, and treated with 3 mMNup153-Cyt c (3 mM) or vehicle (medium) alone
for 4 hr. Fixation and immunostaining with anti-Nup153 antibody (ImmuQuest)
and IgG conjugated to FITC (Sigma) were carried out as above and cells were
viewed under confocal microscopy. When required, Nup153-Cyt c-treated
cells were coincubated with the pan-caspase inhibitor Q-VD-OPh, Non-O-
methylated (20 mM) (Calbiochem, Merck) for 4 hr.
MTT Conversion Assay
Peptide-induced changes in cellular viability were quantitatively assessed
using the 3-(4,5-dimethylthazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
conversion assay (Jones et al., 2008; Carmichael et al., 1987). U373MG cells
were cultured as above in 96-well plates, treated with peptides for 24 hr at
37C, and further incubated with MTT (0.5 mg/ml) for 3 hr at 37C. The insol-
uble formazan product was solubilized with DMSO andMTT conversion deter-
mined by colorimetric analysis at 540 nm. Cellular viability was expressed as
a percentage of those cells treated with vehicle (medium) alone. Graphical
representations of changes in cell viability were calculated using GraphPad
Prism 5 software.
Tunel Assay
Nuclear DNA fragmentation, a characteristic of apoptosis, was detected by the
Tdt (terminal deoxynucleotidyl transferase)-mediated dUTP nick end labeling
(TUNEL) assay according to manufacturer’s instructions (In Situ Cell Death
Detection kit, TMR red, Roche, UK). U373MG cells were grown to 75%
confluence on coverslips in six-well plates, washed, and treated with
peptides or vehicle alone (medium) for 18 hr. Cells were washed with phos-
phate-buffered saline (PBS; pH 7.4) and fixed with 4% (w/v) formaldehyde
in PBS for 1 hr at room temperature. Fixed cells were permeabilized with
0.1% (v/v) Triton X-100 in 0.1% (w/v) sodium citrate at 4C for 2 min and
then incubated for 1 hr at 37C in a humidified atmosphere in the dark with
TUNEL reaction mixture containing Tdt and TMR red-dUTP to label free
30OH ends in the DNA. Coverslips were washed in PBS, air-dried, and
mounted on slides with Vectashield (Vector Laboratories Inc., Peterborough,
UK) containing 4060 diamidino-8-phenylindole dihydrochloride (DAPI) to
counterstain double-stranded DNA in the nuclei. Positive controls were
achieved by incubating fixed and permeabilized cells with DNase I, grade 1
(3000 U/ml in 50 mM Tris-HCl [pH 7.5], 1 mg/ml BSA) for 10 min at room
temperature to induced DNA strand breaks, prior to the labeling procedure.
Negative controls were achieved by incubating fixed and permeabilized cells
in TUNEL reaction mixture without Tdt. Samples were analyzed using a Carl
Zeiss LSM 510 Meta confocal microscope.
Caspase-3 Activation
Detection of caspase-3 activity was measured using the DEVD-NucView 488
caspase-3 substrate (Biotium Inc., Cambridge Bioscience, Cambridge, UK)
according to manufacturer’s instructions. U373MG cells were grown to 75%
confluence in 35 mm sterile glass base dishes (IWAKI) and treated with
peptides or vehicle alone for 4 hr at 37C. Thereafter, DEVD-NucView 488 cas-
pase-3 substrate was added at a final concentration of 5 mM for a further
30 min. As an additional control, treated cells were incubated with the cas-
pase-3 inhibitor Ac-DEVD-CHO (25 mM), 30 min prior to substrate addition.735–744, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 743
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Meta confocal microscope.
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